Southport Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Southport Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,000	Closed	-$15K	–	314
2020 Q4	$15K	Hold	24,000	–	–	0.01%	221
2020 Q3	$13K	Hold	24,000	–	–	0.01%	224
2020 Q2	$16K	Hold	24,000	–	–	0.01%	203
2020 Q1	$18K	Hold	24,000	–	–	0.01%	179
2019 Q4	$36K	Hold	24,000	–	–	0.01%	199
2019 Q3	$36K	Hold	24,000	–	–	0.02%	186
2019 Q2	$31K	Hold	24,000	–	–	0.01%	179
2019 Q1	$63K	Buy	+24,000	New	+$56.3K	0.03%	171

Southport Capital Management's NEOS Position: Q1 2021 in Review

Southport Capital Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 24,000 shares — an estimated $15K sold.

Southport Capital Management first reported a position in NEOS in Q1 2019 and held it in 8 quarters. The position peaked at $63K in Q1 2019. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Southport Capital Management reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Southport Capital Management sold 24,000 Neos Therapeutics, Inc shares in Q1 2021, an estimated $15K.
Southport Capital Management first reported a position in Neos Therapeutics, Inc in Q1 2019 and held it in 8 quarters.
Southport Capital Management's Neos Therapeutics, Inc position peaked at $63K in Q1 2019.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Southport Capital Management's 13F filing for Q1 2021, filed 12 Apr 2021.